Home » William L. Aamoth – Steris
More recent news
- FDA says Medtronic can study Affera pulsed field ablation system for treating ventricular tachycardia
- Analysts see $400B BCI opportunity
- Endostart wins CE mark to bring magnetic balloon tech to enteroscopy
- Neurotech company CeriBell prices $180.3M IPO
- Astellas subsidiary Iota wins FDA IDE nod to study implantable bladder device
